Non-invasive prenatal testing as a valuable source of population specific allelic frequencies

J Biotechnol. 2019 Jun 20:299:72-78. doi: 10.1016/j.jbiotec.2019.04.026. Epub 2019 May 1.

Abstract

Low-coverage massively parallel genome sequencing for non-invasive prenatal testing (NIPT) of common aneuploidies is one of the most rapidly adopted and relatively low-cost DNA tests. Since aggregation of reads from a large number of samples allows overcoming the problems of extremely low coverage of individual samples, we describe the possible re-use of the data generated during NIPT testing for genome scale population specific frequency determination of small DNA variants, requiring no additional costs except of those for the NIPT test itself. We applied our method to a data set comprising of 1501 original NIPT test results and evaluated the findings on different levels, from in silico population frequency comparisons up to wet lab validation analyses using a gold-standard method based on Sanger sequencing. The revealed high reliability of variant calling and allelic frequency determinations suggest that these NIPT data could serve as valuable alternatives to large scale population studies even for smaller countries around the world.

Keywords: Low-coverage massively parallel whole-genome sequencing; Non-invasive prenatal testing; Population specific allelic frequencies.

MeSH terms

  • Computational Biology / economics
  • Female
  • Gene Frequency
  • Genetic Variation*
  • High-Throughput Nucleotide Sequencing / economics
  • High-Throughput Nucleotide Sequencing / methods*
  • Humans
  • Pregnancy
  • Prenatal Diagnosis / economics
  • Prenatal Diagnosis / methods*
  • Reproducibility of Results
  • Slovakia
  • Whole Genome Sequencing / economics